M. Lindsay Grayson

7.5k citations

95 papers · 4.9k indexed · 1 hit paper · h-index 35

Applied Microbiology and Biotechnology top 0.5%
Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 9
Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 13
Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 24
- Infection Control in Healthcare 7
Rehabilitation top 1%
Epidemiology
- Pneumonia and Respiratory Infections 12
- Respiratory viral infections research 9
Pharmacology
- Drug-Induced Adverse Reactions 11
- Antibiotics Pharmacokinetics and Efficacy 9

Co-authors: Benjamin P. Howden John Turnidge George M. Eliopoulos Patrick G. P. Charles Jason A. Trubiano Mary Jane Ferraro Wendy Munckhof Monica A. Slavin
Cited by: Applied Microbiology and Biotechnology Molecular Medicine Clinical Biochemistry
Partner nations: Australia United States Switzerland

In The Last Decade

M. Lindsay Grayson

92 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2017 Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations

Peers

Countries citing papers authored by M. Lindsay Grayson

Since Specialization

Citations

This map shows the geographic impact of M. Lindsay Grayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lindsay Grayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lindsay Grayson more than expected).

Fields of papers citing papers by M. Lindsay Grayson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lindsay Grayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lindsay Grayson. The network helps show where M. Lindsay Grayson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M. Lindsay Grayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Lindsay Grayson Line = papers co-authored together M. Lindsay Grayson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention Misha Devchand,Carl M. J. Kirkpatrick,Wendy Stevenson,Kent Garrett,D. Perera,Sharmila Khumra,Karen Urbancic,M. Lindsay Grayson,Jason A. Trubiano	2019	76
2	Outcomes of an electronic medical record (EMR)–driven intensive care unit (ICU)-antimicrobial stewardship (AMS) ward round: Assessing the “Five Moments of Antimicrobial Prescribing” Misha Devchand,Andrew J. Stewardson,Karen Urbancic,Sharmila Khumra,Andrew A. Mahony,Steven Walker,Kent Garrett,M. Lindsay Grayson,Jason A. Trubiano	2019	12
3	Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (unknown),Walter Zingg,Julie Storr,Benjamin J. Park,John A. Jernigan,Stephan Harbarth,M. Lindsay Grayson,Evelina Tacconelli,Benedetta Allegranzi,Denise M. Cardo,Didier Pittet	2019	8
4	Kucers’ The use of Antibiotics M. Lindsay Grayson	2018	11
5	Core components for effective infection prevention and control programmes: new WHO evidence-based recommendationsbreakdown → (unknown),Julie Storr,Anthony Twyman,Walter Zingg,Nizam Damani,Claire Kilpatrick,J. Reilly,Lesley Price,Matthias Egger,M. Lindsay Grayson,Edward Kelley,Benedetta Allegranzi	2017	334
6	The 3 Cs of Antibiotic Allergy—Classification, Cross-Reactivity, and Collaboration Jason A. Trubiano,Cosby A. Stone,M. Lindsay Grayson,Karen Urbancic,Monica A. Slavin,Karin Thursky,Elizabeth J. Phillips	2017	66
7	Antimicrobial allergy ‘labels’ drive inappropriate antimicrobial prescribing: lessons for stewardship Jason A. Trubiano,Caroline Chen,Allen Cheng,M. Lindsay Grayson,Monica A. Slavin,Karin Thursky	2016	105
8	Back to basics Garry Huang,Andrew J. Stewardson,M. Lindsay Grayson	2014	25
9	Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization A. Cheah,Tim Spelman,Danny Liew,Trisha Peel,Benjamin P. Howden,D. Spelman,M. Lindsay Grayson,Roger L. Nation,David C. M. Kong	2013	112
10	Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis? Bradley J. Gardiner,Andrew A. Mahony,Andrew G. Ellis,Nathan Lawrentschuk,D. Bolton,Phillip T. Zeglinski,Albert G. Frauman,M. Lindsay Grayson	2013	85
11	Diagnosing swine flu: the inaccuracy of case definitions during the 2009 pandemic, an attempt at refinement, and the implications for future planning Andrew A. Mahony,Allen Cheng,Karen L. Olsen,Craig Aboltins,Jim Black,Paul D. R. Johnson,M. Lindsay Grayson,Joseph Torresi	2012	5
12	Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test Bradley J. Gardiner,M. Lindsay Grayson,Gillian Wood	2012	12
13	Use of the “RAM” susceptibility testing method for rapid detection of clarithromycin resistance in the Mycobacterium avium complex Victor Flauta,Gerard Osterhout,Brandon Ellis,M. Lindsay Grayson,Myron Sasser,Sam Cohen,Melissa Sander,Kim Yi Dionne,Karen C. Carroll,Nicole Parrish	2010	2
14	SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community‐Acquired Pneumonia Patrick G. P. Charles,Rory Wolfe,Michael Whitby,Michael J. Fine,Andrew Fuller,Rob G. Stirling,A. A. Wright,Julio A. Ramírez,Keryn Christiansen,Grant Waterer,Robert J. Pierce,John G. Armstrong,Tony M. Korman,Peter W. Holmes,D. Scott Obrosky,Paula Peyrani,Barbara Johnson,Michelle Hooy,M. Lindsay Grayson	2008	372
15	Low-level vancomycin resistance in Staphylococcus aureus?an Australian perspective Benjamin P. Howden,Peter Ward,Paul D. R. Johnson,P. G. P. Charles,M. Lindsay Grayson	2005	15
16	Bactericidal efficacy of sterilizing protocol for reused cardiac electrophysiology catheters Elizabeth A. Grabsch,M. Lindsay Grayson,Paul D. R. Johnson,Lynette A. Yates,Richard W. Harper,Joseph J. Smolich	2002	7
17	Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. C. A. Wanke,Deborah Cohan,Thanason Thummakul,S Jongwuitiwes,M. Lindsay Grayson,Scott M. Hammer,Mattana Hanvanich	1999	16
18	SAFETY OF IMIPENEM IN NEONATES Rhonda L. Stuart,JD Turnidge,M. Lindsay Grayson	1995	10
19	In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria Peter Midolo,Julien R. Lambert,R Hull,Fangping Luo,M. Lindsay Grayson	1995	182
20	Optimum Treatment of Staphylococcal Infections John Turnidge,M. Lindsay Grayson	1993	52

About M. Lindsay Grayson

M. Lindsay Grayson is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Infectious Diseases, having authored 95 papers that have together received 4.9k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (24 papers), Bacterial Identification and Susceptibility Testing (13 papers), Pneumonia and Respiratory Infections (12 papers), Drug-Induced Adverse Reactions (11 papers), Respiratory viral infections research (9 papers), Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Infection Control in Healthcare (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (369 citations), Molecular Medicine (484 citations) and Clinical Biochemistry (636 citations). M. Lindsay Grayson has collaborated with scholars based in Australia, United States and Switzerland. Frequent co-authors include Benjamin P. Howden, John Turnidge, George M. Eliopoulos, Patrick G. P. Charles, Jason A. Trubiano, Mary Jane Ferraro, Wendy Munckhof, Monica A. Slavin, Karin Thursky and Tony M. Korman.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact